2m 2m 2m 2m 2m 2m 2m
Elite Pharmtical (ELTP)
OTC
$0.44+$0.03 (+7.94%)
Price as of Jun 03, 2026- $145.1MMarket Cap
- -22.27%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Elite Pharmtical (ELTP)
$0.44+$0.03 (+7.94%)
ELTP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.43 | ||
Change | +$0.03 (+7.94%) | ||
Open | $0.42 | ||
High | $0.44 | ||
Low | $0.41 | ||
Previous Close | $0.40 | ||
Volume | 1,076,879 | ||
30-Day Average Volume | 570,718 | ||
1-Week Change | 26.86% | ||
1-Month Change | 24.82% | ||
1-Year Change | -22.27% | ||
3-Year Change | 1,142.86% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.0B | ||
Total Assets | $70.7M | ||
Market Cap | $145.1M | ||
Enterprise Value | $140.1M | ||
Period: QTR TTM FY | |||
Revenue | $14.2M | ||
Net Income | $14.9M | ||
Free Cash Flow | -$235,938.00 | ||
EBIT | -$2.6M | ||
EBITDA | -$2.3M | ||
Net Working Capital | $15.7M | ||
EPS | $0.01 | ||
Enterprise Value/EBITDA | -62 | ||
Enterprise Value/Revenue | 10 | ||
P/B | 3 | ||
P/E | 14 | ||
PEG | N/A | ||
Price/Free Cash Flow | -615 | ||
Price/Operating Cash Flow | -615 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||